Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 165   

Articles published

BMY 71.30 +0.55 (0.78%)
price chart
Bristol-Myers Squibb Co (NYSE:BMY) Analyst EstimatesBristol-Myers Squibb Co ...
Bristol-Myers Squibb Co (NYSE:BMY)stock is currently trading at about $71.31 and lots of rating firms seem to have a target price set on the stock.
Howard Capital Management Increased Bristol Myers Squibb Co (NYSE:BMY) by $6 ...  CCH Daily News
HC Stock Overview: ChemoCentryx Inc (NASDAQ:CCXI), Bristol-Myers Squibb Co ...  share market updates (press release)
Is Bristol-Myers Squibb's Valuation High?
On May 24, 2016, Bristol-Myers Squibb (BMY) was trading at a forward PE (price-to-earnings) multiple of ~24.7x, as compared to the industry average of 16.1x.
Bristol-Myers Squibb Co. adding jobs, facilities at Devens
DEVENS - Drugmaker Bristol-Myers Squibb Co. is adding jobs and settling into two new buildings as it works to beef up development of biological medicines.
Bristol-Myers Squibb Co (NYSE:BMY) Analysts Recommendations and Insider Trading  Zergwatch
Bristol-Myers Squibb Co to invest nearly $80M in Puerto Rico  Washington Times
1 Wonder Drug Sends Bristol-Myers Squibb Co. Rocketing 13% Higher in April
What: Shares of Bristol-Myers Squibb (NYSE: BMY), one of the largest pharmaceutical giants in the U.S., vaulted higher by 13% in April and touched a 17-year high, according to data from S&P Global Market Intelligence.
Q2 2016 EPS Estimates for Bristol-Myers Squibb Co (BMY) Lifted by Analyst  Washington News Wire
Insider Selling Activity: Bristol-Myers Squibb Co (NYSE:BMY)  The Point Review
Target Check and Stock Performance Recap Bristol-Myers Squibb Company (NYSE:BMY)
In recent session activity, Bristol-Myers Squibb Company (NYSE:BMY) shares have traded +0.82%. Monitoring the stock price relative to moving averages may provide enhanced perspective on share performance.
Eye-Catching Stocks: BioDelivery Sciences International, Inc. (NASDAQ:BDSI ...
Shares of Bristol-Myers Squibb Co (NYSE:BMY) slipped -1.23% to $69.90 at 11:56 AM EDT. The stock exchanged hands of 2.10 million shares recently versus average trading capacity of 5.79 million shares.
Bristol-Myers Squibb and AbbVie Announce European Commission Approval of ...
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and AbbVie (NYSE:ABBV) announced today that the European Commission has approved Empliciti™ (elotuzumab) for the treatment of multiple myeloma as combination ...
Bristol-Myers Squibb, AbbVie Get European Commission Approval of Multiple ...  Sonoran Weekly Review
AbbVie Inc(NYSE:ABBV) &Bristol-Myers Squibb Co(NYSE:BMY) Healthcare ...  Wall Street 24
Bristol-Myers Squibb Company (NYSE:BMY) Costs Of Goods Sold Stands At $3909 ...
For the fiscal ended 2015-12-31, Bristol-Myers Squibb Company (NYSE:BMY) comprehensive income was $-2468 millions and for the quarter ended 2015-12-31, it was $-2468 millions.
Bristol-Myers Squibb Company (NYSE:BMY) Tracking Stock Rating and Target ...
Out of the 14 covering Wall Street analysts providing share ratings for Bristol-Myers Squibb Company (NYSE:BMY), 7 have rated the stock as a Strong Buy while 1 analysts have the stock listed as a Buy.
Insider Selling in the Spotlight: Bristol-Myers Squibb Co (NYSE:BMY)
Bristol-Myers Squibb Co (NYSE:BMY) insiders have most recently took part in a trading activity. On 5/3/2016 Caforio Giovanni, CEO sold 15,145 shares having total worth of $1,080,172 at the price of $71.32 per share, following the transaction a total of ...
Bristol-Myers Squibb realtor is promoting facility internationally  Meriden Record-Journal
Bristol-Myers Squibb Company (BMY) Analyst Estimates And Rating  Zergwatch